HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

被引：0
|
作者：
Yvonne N. Flores
David M. Bishai
Attila Lőrincz
Keerti V. Shah
Eduardo Lazcano-Ponce
Mauricio Hernández
Víctor Granados-García
Ruth Pérez
Jorge Salmerón
机构：
[1] Instituto Mexicano del Seguro Social,Unidad de Investigación Epidemiológica y en Servicios de Salud
[2] Johns Hopkins University,Department of Population, Family, and Reproductive Health
[3] Bloomberg School of Public Health,Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine
[4] Queen Mary University of London,Department of Molecular Microbiology and Immunology
[5] Johns Hopkins University,Centro de Investigación en Salud Poblacional
[6] Bloomberg School of Public Health,Secretaria de Prevención y Promoción de la Salud
[7] Instituto Nacional de Salud Pública,Unidad de Investigación en Economía de la Salud
[8] Secretaría de Salud,Departamento de Abastecimiento, Instituto Mexicano del Seguro Social
[9] Instituto Mexicano del Seguro Social,undefined
[10] Hospital General Regional No. 1,undefined
来源：
Cancer Causes & Control | 2011年 / 22卷
关键词：
Cost-effectiveness; Cervical cancer; HPV; Screening; Mexico;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：261 / 272
页数：11
相关论文
共 50 条
  • [31] Testing for HPV cost-effective in women with borderline smears
    Szarewski, A
    LANCET, 2000, 355 (9211): : 1247 - 1247
  • [32] Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening
    Chatzistamatiou, Kimon
    Moysiadis, Theodoros
    Moschaki, Viktoria
    Panteleris, Nikolaos
    Agorastos, Theodoros
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 120 - 127
  • [33] BUILDING A BRIDGE TO MORE COST-EFFECTIVE TESTING
    HICKMAN, I
    ELECTRONICS WORLD & WIRELESS WORLD, 1993, (1689): : 688 - 691
  • [34] Could molecular pathology testing in lung cancer be more cost-effective?
    Walsh, Kathy
    Kheng, Yuan Chun
    Oniscu, Anca
    Harrison, David J.
    Wallace, William A.
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (10) : 938 - 941
  • [35] Is HPV testing with cytological triage a more logical approach in cervical cancer screening?
    Franco, Eduardo L.
    Ferenczy, Alex
    LANCET ONCOLOGY, 2006, 7 (07): : 527 - 529
  • [36] Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing
    Pedersen, Kine
    Burger, Emily A.
    Sy, Stephen
    Kristiansen, Ivar S.
    Kim, Jane J.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (02) : 326 - 333
  • [37] THE MOST EFFECTIVE METHOD USING HPV TESTING IN CERVICAL CANCER SCREENING IN JAPAN
    Maehama, T.
    Toma, M.
    Kobayashi, T.
    Oshiro, D.
    Kamiyama, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 333 - 333
  • [38] HPV Testing Is Effective For Cervical Cancer Screening In Low-Resource Settings
    Doskoch, P.
    INTERNATIONAL PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2009, 35 (03) : 156 - 157
  • [39] SCREENING HOSPITAL EMPLOYEES FOR MEASLES IMMUNITY IS MORE COST-EFFECTIVE THAN BLIND IMMUNIZATION
    SELLICK, JA
    LONGBINE, D
    SCHIFELING, R
    MYLOTTE, JM
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) : 982 - 984
  • [40] Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years
    Jin, Xian Wen
    Lipold, Laura
    Foucher, Julie
    Sikon, Andrea
    Brainard, Jennifer
    Belinson, Jerome
    Schramm, Sarah
    Nottingham, Kelly
    Hu, Bo
    Rothberg, Michael B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 (11) : 1338 - 1344
12345